Cross-regulation of RNA methylation modifications and R-loops: from molecular mechanisms to clinical implications Authors: Yuqing Wu, Shen Lin, Hong Chen, Xiangyi Zheng Published: 2024 ABSTRACT AbstractR-loops, RNA–DNA hybrid structures, are integral to key cellular processes such as transcriptional regulation, DNA replication, and repair. However, aberrant accumulation of R-loops can compromise genomic integrity, leading to the development of various diseases. Emerging evidence underscores the pivotal role of RNA methylation modifications, particularly N6-methyladenosine (m6A) and 5-methylcytosine (m5C), in orchestrating the formation, resolution, and stabilization of R-loops. These modifications dynamically regulate R-loop metabolism, exerting bidirectional control by either facilitating or resolving R-loop structures during gene expression regulation and DNA damage repair. Dysregulation of RNA methylation and the resultant imbalance in R-loop homeostasis are closely linked to the pathogenesis of diseases such as cancer and neurodegenerative disorders. Thus, deciphering the cross-talk between RNA methylation and R-loops is essential for understanding the mechanisms underlying genomic stability and identifying novel therapeutic targets. This review provides a comprehensive analysis of the role of RNA methylation in R-loop dynamics, examines their physiological and pathological implications, and proposes future directions for therapeutic intervention targeting these processes.Keywords: Transcriptional regulation, Epitranscriptomics, Genomic stability Introduction The biological significance of R-loops in cellular physiology and pathology During transcription, DNA replication, and DNA damage repair, the nascent RNA strand can hybridize with the DNA template, forming RNA–DNA hybrids. When these hybrids stabilize, they displace the non-template strand, resulting in a structure known as an R-loop. Although "RNA–DNA hybrids" and "R-loops" are sometimes used interchangeably, single-molecule R-loop footprinting combined with DNA sequencing has shown that most RNA–DNA hybrids exist in the form of R-loops in vivo [1]. This finding suggests that R-loops are a common feature of co-transcriptional processes and are one of the predominant DNA structures formed during these processes. Under normal physiological conditions, R-loops are widespread in highly transcribed genes and participate in several essential biological processes, including immunoglobulin class-switch recombination (CSR), gene expression, DNA replication, DNA damage repair, and the regulation of transcription initiation and termination [2–4]. The generation and resolution of R-loops are tightly regulated by various factors, and their coordinated action maintains R-loop homeostasis, safeguarding genomic integrity [5, 6]. For example, R-loops play a regulatory role during transcription initiation and termination, ensuring proper transcription progression and contributing to DNA damage repair [7]. Additionally, R-loops formed near gene promoters have been shown to regulate gene expression by stabilizing certain transcription start sites, especially in genes with G-rich promoter sequences [8]. Furthermore, R-loops can regulate chromatin modifications, such as DNA demethylation and histone modifications, contributing to their emerging role as regulatory structures in normal gene expression [9, 10]. However, when regulatory factors become defective or mutated, R-loops can accumulate abnormally at inappropriate locations and times. This pathological accumulation disrupts normal processes such as DNA replication, repair, and transcription, becoming a significant source of genomic instability and contributing to various diseases [11–13]. For instance, in myelodysplastic syndromes (MDS), mutations in splicing factors such as SF3B1, U2AF1, and SRSF2 lead to the abnormal accumulation of R-loops, which in turn causes DNA damage and genomic instability [14, 15]. To counteract the formation of pathological RNA–DNA hybrids, cells have evolved multiple mechanisms for their clearance, including RNA-binding proteins, ribonucleases, and proteins involved in DNA replication and repair [3, 16, 17]. These mechanisms are crucial for maintaining genomic stability and ensuring normal cellular function. A deeper understanding of the biological significance and regulatory mechanisms of R-loops will provide valuable insights into their roles in both physiological and pathological conditions, potentially paving the way for novel strategies in disease prevention and treatment. The regulatory role of RNA methylation in R-loops RNA methylation plays a pivotal role in molecular regulation, influencing various aspects of RNA metabolism, including splicing, translation, stability, localization, and secondary structure [18, 19]. In recent years, research on RNA modifications has expanded to encompass a wide range of physiological processes, such as the DNA damage response, viral infection, cell differentiation, brain development, cell growth, and tumor progression [20–23]. RNA methylation, particularly m6A and m5C modifications, has emerged as critical in regulating the formation, resolution, and stability of R-loops. As unique structures formed by the interaction between DNA and RNA, the dynamic balance of R-loops is essential for maintaining genomic stability and regulating gene expression. RNA methylation plays a central role in R-loop metabolism, thereby influencing genomic integrity, transcriptional control, and DNA damage repair (Fig. 1). Key RNA methylation writers and readers modulate R-loop formation and stability RNA methylation types such as m6A, m5C, and m3C, play pivotal roles in regulating R-loop metabolism. The methyltransferases METTL3 and METTL14 mediate m6A modification, while TRDMT1 and METTL8 mediate m5C and m3C, respectively. These "writers" work in concert with "reader" proteins like YTHDC1, YTHDF2, and FMRP, which recognize methylated RNA and help resolve or stabilize R-loops. Disruption in this regulation may result in abnormal R-loop accumulation, contributing to genomic instability Recently, there has been increasing interest in the role of RNA modifications in regulating R-loops. Abakir et al. were the first to employ antibody-based DNA-RNA immunoprecipitation (DRIP) combined with m6A-DIP to isolate m6A-modified RNA–DNA hybrids in human pluripotent stem cells [24]. A high degree of overlap between m6A-DIP-seq and DRIP-seq datasets revealed that m6A-modified RNA–DNA hybrids preferentially accumulate at specific genomic regions, including transcriptional and repetitive sequences, suggesting that a majority of RNA–DNA hybrids are m6A-modified. Moreover, methylation-related proteins, such as methyltransferases, demethylases, and methylation reader proteins, dynamically regulate RNA methylation on R-loops. Studies have demonstrated that m6A RNA methylation is crucial for R-loop resolution [24], while m5C demethylation mediated by the methylation reader protein FMRP is involved in R-loop degradation [25]. These findings illustrate the dynamic and reversible nature of RNA methylation on R-loops, underscoring its regulatory role in R-loop metabolism and its implications for disease progression and therapeutic outcomes. Dysregulation of RNA methylation can result in abnormal R-loop accumulation, which further promotes genomic instability and disrupts DNA repair mechanisms. In pathological conditions such as cancer and neurological disorders, the combined dysregulation of R-loops and RNA methylation exacerbates cellular dysfunction and accelerates disease progression [25, 26]. This review highlights recent advancements in understanding RNA modifications on R-loop structures, particularly the effects of methylation on R-loop metabolism, and examines how changes in R-loop stability contribute to disease progression and drug resistance. These insights lay the groundwork for further exploration of the roles of RNA methylation and R-loop regulation in disease mechanisms. RNA methylation types such as m6A, m5C, and m3C, play pivotal roles in regulating R-loop metabolism. The methyltransferases METTL3 and METTL14 mediate m6A modification, while TRDMT1 and METTL8 mediate m5C and m3C, respectively. These "writers" work in concert with "reader" proteins like YTHDC1, YTHDF2, and FMRP, which recognize methylated RNA and help resolve or stabilize R-loops. Disruption in this regulation may result in abnormal R-loop accumulation, contributing to genomic instability. The role of RNA methylation in regulating R-loop stability The dual role of m6A methylation in R-loop formation and stability m6A is the most prevalent and reversible RNA methylation modification, primarily mediated by the methyltransferase complex composed of METTL3, METTL14, and WTAP during transcription [27]. In recent years, numerous studies have highlighted the critical role of m6A modifications in regulating R-loop formation and stability [28, 29]. Research has demonstrated that m6A-associated methyltransferases are indispensable for the formation and stabilization of R-loops. Using single-strand DNA ligation-based library construction of DNA:RNA hybrid immunoprecipitation and sequencing (ssDRIP-seq), it was revealed that m6A modifications are added to RNA during transcription by the methyltransferase METTL3, particularly near transcription termination sites (TESs), thereby promoting the formation of R-loops [30]. Additionally, METTL3 stabilizes telomeric repeat-containing RNA (TERRA), facilitating the formation of R-loops in telomeric regions, further underscoring the role of m6A in R-loop formation [31, 32]. Moreover, studies indicate that m6A is not only involved in R-loop formation but also plays a dynamic role in regulating their resolution. At sites of DNA double-strand breaks (DSBs), METTL3 is activated via ATM-dependent phosphorylation and is recruited to the break site, where it catalyzes m6A modifications on RNA, promoting the formation of DNA-RNA hybrids. Conversely, the demethylase FTO can remove m6A modifications, thereby reducing R-loop formation, which highlights the bidirectional regulatory role of m6A in maintaining R-loop homeostasis [33]. Furthermore, m6A enhances R-loop stability through interactions with specific reader proteins. YTHDC1, a primary m6A reader, recognizes and binds to m6A-modified RNA, thereby preventing its degradation and preserving R-loop integrity [33]. In the case of TERRA R-loops, YTHDC1 binds to m6A-modified TERRA, preventing excessive degradation and maintaining telomere stability [31]. Additionally, the insulin-like growth factor-binding protein (IGFBP) family, another group of m6A readers, recognizes and binds m6A-modified RNA via their KH domains. These proteins competitively interact with YTHDF2 to bind R-loops, further preventing their dissociation and enhancing their stability [26]. These findings suggest that m6A not only directly promotes R-loop formation but also collaborates with various RNA-binding proteins to sustain the long-term stability of R-loops. The role of m6A in R-loop resolution and genomic stability Excessive accumulation of R-loops is frequently linked to incomplete resolution, and the absence of RNA methylation or inactivation of associated proteins can hinder the effective clearance of R-loops. Thus, m6A modification plays a crucial role in resolving R-loops and maintaining genomic stability by preventing their excessive accumulation and protecting genomic integrity. m6A writer proteins facilitate the involvement of other resolution factors through their catalytic activity. For example, the transcriptional regulator TonEBP, via its Rel homology domain (RHD), interacts with METTL3's zinc finger domain, recruiting METTL3 to R-loop regions for m6A modification. TonEBP further recruits RNase H1 to these R-loop sites, aiding in their resolution [34]. Similarly, ARID1A directly binds to R-loops and recruits METTL3 to DSB sites, enhancing m6A modification of R-loops and promoting RNase H1 binding, which facilitates R-loop resolution [35]. In this process, the m6A modification catalyzed by METTL3 becomes a critical step for the efficient recognition and resolution of R-loops by RNase H1, ensuring R-loop homeostasis. m6A reader proteins also play an essential role in R-loop resolution. YTHDF2, a key m6A reader, primarily recognizes and binds to R-loops in repetitive sequences and intronic regions, regulating their resolution [24]. In prostate cancer, YTHDF2 binds to m6A-modified RNA through its YTH domain, initiating the resolution of R-loops [26]. Although the exact mechanism by which YTHDF2 regulates R-loop resolution remains unclear, it is speculated that YTHDF2 recruits enzymes that either cleave or unwind RNA–DNA hybrids, or specific nucleases such as RNase P or MRP, which cleave m6A-modified RNA, thereby influencing R-loop stability [36]. Helicases interacting with m6A modifications also play a critical role in R-loop resolution. For instance, DDX21 interacts with METTL3 to regulate m6A-modified R-loop sites, thereby ensuring precise helicase activity [37]. Additionally, DDX41 works in conjunction with YTHDC1 to regulate m6A-modified R-loop resolution. Mutations in DDX41 impair YTHDC1's interaction with the MAC complex, leading to defective R-loop resolution and subsequent R-loop accumulation [38]. In summary, m6A modification, in collaboration with various regulatory factors and proteins, ensures the proper resolution and degradation of R-loops, thereby maintaining genomic stability. This dynamic regulatory mechanism is essential for the control of both R-loop formation and stability. Non-m6A methylation modifications in R-loop regulation: m5C and m3C Following our discussion of m6A's role in R-loop formation and resolution, it is important to recognize that other RNA modifications, such as m5C and 3-methylcytosine (m3C), also play critical roles in the formation, accumulation, and resolution of R-loops. These modifications influence the dynamic equilibrium of R-loops through various proteins and regulatory pathways. Research has shown that m5C contributes to R-loop regulation through several mechanisms. In breast cancer, TRDMT1 (also known as DNMT2), an RNA methyltransferase, introduces m5C modifications into R-loops, stabilizing their formation in specific regions [39]. This stabilization is particularly notable in G-rich regions, where m5C strengthens the interaction between RNA and C-rich DNA strands, thermodynamically enhancing R-loop stability and promoting their accumulation in certain genomic loci [40]. Moreover, FMRP, a specific reader protein for m5C, plays a pivotal role in R-loop regulation. FMRP preferentially binds to m5C-modified R-loops, increasing their stability while also promoting their resolution through its interaction with TET1, an m5C demethylase [25]. This dual role of m5C—facilitating R-loop formation and stability via TRDMT1 and promoting resolution through the FMRP-TET1 interaction—highlights a dynamic regulatory mechanism. METTL8, another RNA methyltransferase, influences R-loop formation and resolution through its catalytic activity on 3-methylcytosine (m3C). Studies have shown that after SUMOylation, METTL8's catalytic activity is significantly enhanced, leading to tighter interactions with R-loops and affecting the balance between R-loop accumulation and resolution [41]. The increased catalytic activity of METTL8 promotes persistent R-loop accumulation, while its capacity for resolution diminishes, ultimately leading to abnormal R-loop aggregation. Furthermore, METTL8 regulates the stability of mitochondrial tRNA (mt-tRNA) through m3C modifications and promotes R-loop formation in ribosomal DNA regions within glioblastoma stem cells (GSCs) [42]. Although the precise mechanism of METTL8 in R-loop resolution remains unclear, it is hypothesized that different isoforms of METTL8 may cooperate with other RNA-binding proteins to regulate R-loop resolution, exhibiting diverse regulatory functions depending on the cellular context. These findings underscore the complexity of RNA methylation in R-loop biology, highlighting the diverse ways in which these modifications influence genome stability. The role of R-loops and RNA methylation in DNA damage repair Genomic instability induced by R-loop accumulation and the regulatory role of methylation The proper formation and regulation of R-loops are essential for maintaining genomic stability. However, excessive accumulation or incomplete resolution of R-loops can lead to transcription-replication conflicts (TRCs), resulting in DNA replication obstacles, DSBs, and genomic instability [43]. RNA methylation plays a pivotal regulatory role by controlling both the formation and resolution of R-loops, ensuring their dynamic balance. When this balance is disrupted, abnormal R-loop accumulation can directly compromise genomic integrity (Fig. 2). RNA methylation dysregulation promotes R-loop accumulation and genomic instability. When RNA methylation writers and readers, such as METTL3/METTL14 (m6A writer) and YTHDC1 (m6A reader), are dysregulated, the formation and resolution of R-loops become impaired. This results in increased R-loop accumulation, leading to TRCs and DSBs, both of which contribute to genome instability. Such genomic instability is a key factor in the development of diseases, including cancer and neurological disorders For example, in patients with MDS harboring DDX41 mutations, excessive R-loop accumulation is a significant contributor to genomic instability. Under normal conditions, DDX41 interacts with METTL3/METTL14 and YTHDC1 to regulate R-loop formation and dissolution. However, mutations in DDX41 impair this regulatory function, leading to R-loop accumulation and an increased risk of DNA damage [38]. During transcription termination, R-loop accumulation is closely associated with genomic instability. m6A modifications, mediated by METTL3, regulate R-loop formation and resolution, ensuring proper transcription termination. Inadequate m6A modification can prevent RNA polymerase II from pausing effectively, resulting in transcriptional elongation, increased TRC frequency, and a higher incidence of DSBs, thereby exacerbating DNA damage and genomic instability [30, 37]. Additionally, the inactivation of DDX21 further impairs R-loop resolution, exacerbating transcriptional elongation and worsening genomic damage [37]. R-loop accumulation in telomeric regions is also strongly linked to genomic instability. TERRA forms R-loops to maintain telomere stability, and METTL3 stabilizes TERRA-associated R-loops via m6A modification. However, insufficient m6A modification destabilizes TERRA, reducing R-loop formation and leading to telomere shortening and genomic instability [31, 32]. Moreover, m3C modifications also play a role in R-loop-induced genomic instability. SUMOylated METTL8 promotes R-loop formation through m3C modification, particularly in GC-rich regions. Dysfunctional METTL8 or disrupted SUMOylation decreases R-loop formation, increasing genomic instability and transcriptional dysregulation [41]. In summary, excessive R-loop accumulation is a key driver of genomic instability and DNA damage. RNA methylation regulates the dynamic balance of R-loops and plays a central role in maintaining genomic stability. Dysregulation of either m6A or m3C modifications can lead to increased R-loop accumulation, significantly raising the risk of DNA damage. This underscores the critical role of methylation in regulating R-loops and its profound impact on genomic integrity. When RNA methylation writers and readers, such as METTL3/METTL14 (m6A writer) and YTHDC1 (m6A reader), are dysregulated, the formation and resolution of R-loops become impaired. This results in increased R-loop accumulation, leading to TRCs and DSBs, both of which contribute to genome instability. Such genomic instability is a key factor in the development of diseases, including cancer and neurological disorders. The role of R-loops and RNA methylation in DNA damage repair Following DNA damage, particularly during DSBs, complex repair mechanisms are activated, and the formation and resolution of R-loops play crucial regulatory roles in this process. RNA methylation, especially m6A and m5C modifications, significantly influences the progression and efficiency of the repair process by regulating the dynamic balance of R-loops. m6A modification plays a pivotal role in DNA damage repair. Studies have demonstrated that METTL3 regulates R-loop formation and resolution via m6A modifications. After a DSB, if METTL3 or m6A modifications are insufficient, the recruitment of key repair proteins such as RAD51 and BRCA1 is impaired, leading to delayed DNA damage responses and a substantial reduction in repair efficiency [33, 38]. Inadequate m6A modification can also result in the accumulation of DNA-RNA hybrids, further obstructing the initiation of normal repair pathways, exacerbating the damage caused by DNA breaks [34]. m5C modifications are equally important in DNA damage repair. TRDMT1 stabilizes R-loops by generating m5C modifications, facilitating the binding of repair proteins. Cells deficient in TRDMT1 show significantly reduced homologous recombination repair efficiency, with repair proteins such as RAD51 and RAD52 failing to localize effectively to sites of DNA damage induced by reactive oxygen species (ROS) [39]. Additionally, FMRP, through its interaction with TET1, regulates m5C demethylation, promoting R-loop resolution. A lack of or reduced expression of FMRP leads to abnormal accumulation of m5C-modified R-loops, delaying their resolution and impeding DSB repair, thereby increasing the risk of persistent DNA damage [25]. R-loop resolution depends not only on RNA methylation but also on the action of specific enzymes. Methylation modifications assist in the recruitment of RNase H1, a key enzyme responsible for resolving R-loops. By preventing the excessive accumulation of R-loops, RNase H1 ensures proper DNA end resection and smooth progression of homologous recombination repair. For instance, ARID1A recruits METTL3 to methylate R-loops with m6A, promoting RNase H1 binding and accelerating R-loop resolution, which is crucial for efficient DNA repair [35]. In summary, RNA methylation plays a central role in DNA damage repair by regulating R-loop formation, accumulation, and resolution. By facilitating R-loop resolution and recruiting repair proteins, methylation ensures timely and efficient DNA damage repair. Mutations or functional disruptions in these methylation pathways can impair normal R-loop resolution, ultimately threatening genomic stability. The impact of methylation and R-loops on DNA damage repair pathway selection In response to DNA damage, the selection of the appropriate repair pathway is crucial, particularly in balancing homologous recombination (HR) and non-homologous end joining (NHEJ). RNA methylation, especially m6A and m5C modifications, significantly influences R-loop formation and resolution, thereby modulating the recruitment of repair proteins and determining the choice between different repair pathways (Fig. 3). R-loop regulation influences the choice between HR and Alt-NHEJ during DNA damage repair. In the presence of DSBs, R-loops may form at break sites, affecting the repair pathway selection. m6A and m5C modifications can facilitate HR by recruiting repair proteins such as RAD51/RAD52. In contrast, the failure to resolve R-loops can lead to the activation of Alt-NHEJ, mediated by PARP1 and associated proteins m6A modification plays a key role in repair pathway selection. Studies have shown that cells lacking METTL3 exhibit a marked reduction in HR repair efficiency, while NHEJ repair remains relatively unaffected [33]. This suggests that m6A modification is essential for HR repair, and in its absence, cells shift their preference toward NHEJ. Furthermore, a reduction in the binding capacity of YTHDC1 to RAD51 compromises RAD51 recruitment to DNA damage sites, further weakening HR repair efficiency [38]. ARID1A ensures the preferential selection of HR repair by regulating m6A modifications on R-loops. ARID1A recruits METTL3 to DNA damage sites, promoting m6A modification of R-loops, and facilitates the recruitment of RNase H1 to dissolve R-loops, ensuring the smooth progression of HR repair [35]. m5C modification also plays a critical role in repair pathway selection. Studies have shown that TRDMT1-mediated m5C modifications at DNA damage sites enhance the binding of repair proteins such as RAD52 and RAD51 to R-loops, thereby promoting HR repair [39]. In TRDMT1-deficient cells, NHEJ repair is enhanced, indicating that m5C modification favors the high-fidelity HR repair pathway. Additionally, TRDMT1-mediated m5C modification has been shown to inhibit the alternative non-homologous end joining (Alt-NHEJ) pathway. m5C modification suppresses the activation of PARP1, reducing the recruitment of Alt-NHEJ repair proteins like XRCC1 and LIG3, thereby promoting HR repair. PARP inhibitor studies further support the role of m5C modification in repair pathway selection, demonstrating that m5C limits Alt-NHEJ activity and favors HR repair [40]. FMRP also facilitates HR repair by regulating m5C demethylation and R-loop resolution. Unlike other repair factors, FMRP enhances HR repair efficiency by promoting RAD51 recruitment independently of the BRCA1/BRCA2 pathway, highlighting the unique regulatory role of m5C modification in ensuring the efficiency of HR repair [25]. In conclusion, RNA methylation influences DNA damage repair pathway selection by regulating R-loop dynamics and the recruitment of repair proteins. Disruptions in methylation modifications not only interfere with R-loop homeostasis but also lead to improper repair pathway selection, ultimately compromising genomic stability. In the presence of DSBs, R-loops may form at break sites, affecting the repair pathway selection. m6A and m5C modifications can facilitate HR by recruiting repair proteins such as RAD51/RAD52. In contrast, the failure to resolve R-loops can lead to the activation of Alt-NHEJ, mediated by PARP1 and associated proteins. The role of R-loops and RNA methylation in disease RNA methylation and R-loop dysregulation are implicated in a wide range of diseases, including cancer, neurological disorders, and hematological conditions. These mechanisms play critical roles in disease progression by influencing genomic stability and DNA repair (Table 1). Table 1Overview of diseases associated with RNA methylation and R-loop dysregulation [25, 32, 34, 35, 38, 39, 41, 42, 44]DiseaseRNA methylation typeConsequences of R-loop dysregulationNeuroblastomam6AIncreased stability of R-loops, leading to the accumulation of telomere-associated RNA (TERRA), disrupting telomere length maintenance, promoting genomic instability, and accelerating tumor cell growthBreast, Ovarian, Lung Cancersm6A, m5C (in breast cancer)Insufficient R-loop resolution regulated leading to R-loop accumulation, impaired DNA damage repair, genomic instability, and accelerated tumor progressionGlioblastomam3CMETTL8 increases mt-tRNA stability through m3C modification, promoting R-loop accumulation, activating the HIF1α/RTK/Akt pathway, enhancing tumor self-renewal capacity and therapy resistanceFragile X Syndromem5CImpaired R-loop resolution regulated by FMRP, leading to R-loop accumulation during transcription, causing genomic instability and neurological dysfunction, resulting in intellectual disabilities and neurodegenerationAlzheimer's and Parkinson's Diseasesm6A, m5CDysregulated RNA methylation leads to impaired R-loop resolution, causing DNA damage repair deficiencies, neuronal degeneration, and cell death, contributing to the progression of neurodegenerative disordersMyelodysplastic Syndromesm6AMutations in DDX41 lead to abnormal R-loop accumulation, impairing DNA repair mechanisms and causing genomic instability, accelerating disease progression Overview of diseases associated with RNA methylation and R-loop dysregulation [25, 32, 34, 35, 38, 39, 41, 42, 44] R-loops and RNA methylation in cancer The abnormal accumulation of R-loops and dysregulation of RNA methylation play pivotal roles in various types of tumors. RNA methylation, by modulating the formation, resolution, and stability of R-loops, directly influences tumor initiation, progression, and therapeutic response. In many tumors, m6A modification impacts genomic stability and tumor cell proliferation by regulating R-loop stability and resolution. METTL3 is crucial in neuroblastoma, where it regulates the formation of TERRA RNA R-loops in telomeric regions through m6A modification, thereby maintaining telomere stability. The excessive accumulation of TERRA is closely associated with the activation of the alternative lengthening of telomeres (ALT) pathway, a mechanism that accelerates tumor cell growth. The loss of METTL3 disrupts TERRA localization, leading to telomere damage, which further promotes tumor development and progression [31]. Similarly, in ovarian, breast, and lung cancers, ARID1A recruits METTL3 and RNase H1 to regulate R-loop resolution, ensuring DNA damage repair and genomic stability. The absence of METTL3 impairs R-loop resolution, resulting in defective repair and genomic instability, which exacerbates cancer progression [35]. Beyond m6A modification, METTL8, a key enzyme for m3C modification, plays an important role in tumor progression. METTL8 regulates R-loop formation via m3C modification, enhancing the survival and self-renewal capacity of GSCs. By increasing m3C modifications in mt-tRNA, METTL8 activates the HIF1α/RTK/Akt pathway, promoting tumor invasiveness and resistance to therapy [42]. Additionally, methylation-related reader proteins play critical roles in tumor suppression. For instance, IGF2BPs inhibit tumor cell proliferation and migration in prostate cancer by recognizing m6A-modified R-loops, exerting tumor-suppressive effects. This mechanism involves blocking the interaction between DNA methyltransferase DNMT1 and promoter regions, preventing abnormal DNA methylation and consequently inhibiting abnormal cell proliferation [26]. Similarly, dysfunction of FMRP leads to the abnormal accumulation of R-loops in breast cancer, further disrupting transcription and DNA repair, driving tumor initiation and progression [39]. In glioblastoma, m6A modification interacts with YTHDC1 to regulate the formation of R-loops in circPOLR2B and its parent gene POLR2B, enhancing the self-renewal and invasiveness of tumor cells through downstream regulation of the PBX1 gene [44]. In summary, dysregulation of m6A, m5C, and m3C modifications promotes tumor cell proliferation, invasiveness, and treatment resistance by affecting R-loop formation and resolution, underscoring the central role of RNA methylation and R-loops in tumor development and progression. R-loops and RNA methylation in other diseases In addition to its pivotal role in tumors, the dysregulation of R-loops and RNA methylation also plays a critical role in other diseases, particularly hematological disorders and neurological conditions. In MDS, the accumulation of R-loops is closely linked to DNA damage driven by disrupted m6A modifications. In MDS patients, unresolved R-loops with aberrant m6A modifications lead to increased genomic instability and impaired DNA damage repair, contributing to the onset and progression of MDS [38]. In neurological disorders such as fragile X syndrome, R-loop accumulation is associated with the dysfunction of FMRP. Fragile X syndrome, a common hereditary neurological disorder, is primarily caused by the absence of FMRP. FMRP regulates the demethylation of m5C on R-loops, ensuring their timely resolution to maintain transcriptional regulation and genomic stability in neurons. In the absence of FMRP, m5C-modified R-loops fail to resolve properly, leading to genomic instability, transcriptional dysregulation, and ultimately, neurological dysfunction [25]. Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are also closely associated with R-loop accumulation and RNA methylation dysregulation. In Alzheimer's disease, altered m6A and m5C modifications reduce the efficiency of R-loop resolution and impair DNA damage repair, triggering neuronal degeneration and cell death. Similarly, in Parkinson's disease, the interplay between R-loops and dysregulated RNA methylation exacerbates neurodegenerative changes, accelerating disease progression [34]. Additionally, mutations in helicases like SETX (Senataxin) impair R-loop resolution, leading to their pathological accumulation in neurodegenerative diseases. This has been shown to result in increased DNA DSBs, which contribute to the progression of neurodegeneration [10, 45]. In summary, RNA methylation, through its regulation of R-loop formation and resolution, broadly influences genomic stability and DNA repair capacity. Whether in hematological disorders like MDS or neurological diseases such as Alzheimer's disease and fragile X syndrome, the dysregulation of R-loops and RNA methylation leads to genomic instability and impaired DNA damage repair, further driving disease progression. A deeper understanding of these mechanisms will support the development of novel therapeutic strategies targeting RNA methylation and R-loop regulation in the future. Future research directions and therapeutic targets Future research directions RNA methylation and R-loop regulation are essential for cellular function and disease progression. Future research can delve deeper into several promising areas. One of the most pressing challenges in the field of RNA methylation and R-loop research is the development of more precise tools for detecting R-loops in vivo. While DRIP-seq has been instrumental in mapping R-loops genome-wide, it lacks the resolution necessary to pinpoint the exact start and end points of R-loops. Novel techniques, such as R-ChIP, which uses a catalytically dead RNase H1, are improving our ability to visualize R-loop dynamics, but further refinement is needed [46, 47]. While current studies have predominantly focused on m6A and m5C modifications, the roles of other RNA methylations, such as N1-methyladenosine (m1A) and pseudouridine (Ψ), in R-loop regulation remain largely unexplored. These modifications may interact with m6A and m5C to influence R-loop formation and stability. Future research should aim to elucidate the specific mechanisms of these lesser-studied modifications, particularly how they collaborate with m6A and m5C to regulate R-loop dynamics, and their broader implications for cellular functions, genomic stability, and disease development. The regulatory mechanisms of RNA methylation and R-loops likely vary across different cell types, which presents another crucial area for investigation. The regulation of R-loops and RNA methylation in neurons, stem cells, and cancer cells may exhibit distinct characteristics. For example, the processes governing R-loop regulation in neurons may differ significantly from those in stem or cancer cells. Understanding these differences could provide key insights into the specific pathological processes in various tissues and diseases, offering more targeted approaches for therapeutic intervention. Additionally, further exploration of the molecular mechanisms linking R-loops and RNA methylation to disease pathogenesis is critical. Although their roles in cancer and neurological disorders have been identified, many details remain unclear—particularly the specific regulatory pathways involved in different diseases. A deeper understanding of these mechanisms will provide a solid theoretical foundation for the development of targeted therapeutic strategies in the future. Potential therapeutic targets Recent studies have expanded our understanding of RNA methylation's therapeutic potential, particularly in targeting m6A-modified RNA within R-loops. In cancers such as leukemia and glioblastoma, inhibitors targeting the m6A writer METTL3 have been shown to destabilize R-loops and reduce DNA damage, thereby offering potential new avenues for cancer therapy [10, 36]. Clinical trials are also exploring the use of RNA methylation inhibitors to manipulate RNA stability, with potential therapeutic applications for neurodegenerative diseases and viral infections [48]. The ability to target the epitranscriptomic landscape with small molecules, such as FTO inhibitors, represents a promising future for disease intervention [10, 36]. Developing small-molecule drugs that specifically regulate R-loop formation and resolution, such as RNA helicase activators or inhibitors, represents a promising direction for future therapies. For instance, HDAC inhibitors like Romidepsin have been proposed as potential therapeutic agents, as they induce R-loop formation and counteract YTHDC1-mediated R-loop stabilization, thereby improving treatment outcomes in diseases such as glioblastoma [44]. In addition, combining RNA degradation strategies with drugs targeting methylation modifications may offer more comprehensive therapeutic effects. For example, combining METTL3-targeting drugs with RNase H1 activators could enhance R-loop resolution and promote DNA damage repair. Similarly, drugs designed to target R-loop degradation—using specific nuclease systems—coupled with methylation-modifying agents could effectively reduce abnormal R-loop accumulation, restore genomic stability, and improve outcomes in R-loop-associated diseases. Furthermore, integrating interventions targeting both RNA and DNA methylation modifications could lead to novel therapeutic strategies. Drugs that modulate the interaction between RNA and DNA methylation could help regulate the dynamic balance of R-loops, thereby maintaining genomic homeostasis. This approach holds significant potential for application in treating tumors and hereditary diseases and could represent a major breakthrough in therapeutic development. In conclusion, future research should focus on the regulatory mechanisms governing RNA methylation and R-loops, exploring how these mechanisms contribute to various diseases and developing novel therapeutic strategies targeting these pathways. By combining targeted drugs, RNA degradation approaches, and epigenetic interventions, more precise and effective treatments for R-loop-related diseases may be achieved in the future. Acknowledgements We thank all members of Xie’s Lab for their support, with special thanks to Yufan Ying for his valuable assistance during the revision process. Abbreviations N6-methyladenosine 5-Methylcytosine 3-Methylcytosine Double-strand break Homologous recombination Non-homologous end joining Alternative non-homologous end joining Transcription-replication conflict Telomeric repeat-containing RNA Fragile X mental retardation protein Ribonuclease H1 YTH domain containing 1 Methyltransferase Like 3 Methyltransferase Like 14 TRNA Methyltransferase 1 Insulin-like growth factor binding protein Splicing Factor 3b, Subunit 1 U2 Small Nuclear RNA Auxiliary Factor 1 Serine and Arginine Rich Splicing Factor 2 Ataxia Telangiectasia Mutated Ribonuclease P Breast Cancer Type 1 Susceptibility Protein RAD51 Recombinase Poly(ADP-Ribose) Polymerase 1 Reactive Oxygen Species DNA Methyltransferase 1 Pre-B-Cell Leukemia Homeobox 1 Hypoxia-Inducible Factor 1 Alpha Glioblastoma stem cell Wilms Tumor 1-Associated Protein Myelodysplastic Syndromes DEAD-Box Helicase 41 Ten-Eleven Translocation Methylcytosine Dioxygenase 1 Alternative Lengthening of Telomeres DNA-RNA immunoprecipitation R-loop chromatin immunoprecipitation Author’s contributions All authors contributed to the study conception and design. Data collection and analysis were performed by Yuqing Wu and Shen Lin. The first draft of the manuscript was written by Yuqing Wu and Hong Chen, and revised by Xiangyi Zheng. All authors read and approved the final manuscript. Funding This work was supported by grants from the National Natural Science Foundation of China 81972374. Zhejiang Province Medical and Health Scientific Research Project (2023RC154). Availability of data and material Not applicable. Declarations Conflict of interests The authors have no relevant financial or non-financial interests to disclose. Ethical approval and consent to participate Not applicable. Consent for publication Not applicable. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Not applicable.